article thumbnail

Innovation in immuno-oncology: Leading companies in in-vitro T-cell activation

Pharmaceutical Technology

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Immuno-oncology in Pharmaceuticals: In-vitro T-cell activation. Immatics is the leading patent filer in in-vitro T-cell activation.

In-Vitro 130
article thumbnail

In vitro gametogenesis: the science has to be right, and it has to be safe


Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own journey and insights on In vitro gametogenesis (IVG).


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study: Prednisone does not improve in vitro fertilization outcomes

Medical Xpress

Among patients with recurrent implantation failure during in vitro fertilization, treatment with prednisone does not improve the live birth rate versus placebo, according to a study published in the May 2 issue of the Journal of the American Medical Association (JAMA).

article thumbnail

Skipping Informed Consent for In Vitro Diagnostic (IVD) Trials: Understanding the Exceptions


Understanding the exceptions in Informed consent is an essential aspect of ethical clinical research because it concerns full awareness of risks and benefits related to research, as well as procedures. This is particularly relevant for infectious diseases where rapid diagnosis and treatment are important in disease control before its spread.

article thumbnail

In Vitro Pharmacology Working Group to address data standards

Drug Discovery World

A new In Vitro Pharmacology Working Group to accelerate regulatory submissions has been created by the Pistoia Alliance, a global advocate for greater collaboration in life sciences R&D. The post In Vitro Pharmacology Working Group to address data standards appeared first on Drug Discovery World (DDW).

article thumbnail

A Review Of The Regulatory Landscape for In Vitro Gametogenesis

WCG Clinical

To view it please enter your password below: Password: The post A Review Of The Regulatory Landscape for In Vitro Gametogenesis appeared first on WCG. This content is password protected.

article thumbnail

Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application?

Drug Discovery World

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. Participants will gain insight into the specific needs and utility for in vitro ADME and DDI investigations in the drug development process.